 |
|
|
|
|
|
|
| Article 1 to 10 out of 10 concerning Beckman Coulter, Inc.
|
-
Phenomenex to Distribute Beckman Coulter's IgY Proteome Enrichment Chemistry for Biomarker Discovery
(11 Jun 2007)
Phenomenex Inc. announced a distribution agreement for Beckman Coulter's ProteomeLab IgY enrichment products for proteomics and biomarker discovery. The agreement grants Phenomenex exclusive distribution rights in the United States, Canada and ...
-
Beckman Coulter and Biosite Amend Definitive Acquisition Agreement
(04 May 2007)
Strategic Rationale and Economics of Combination Support Increased Price of $90 per Biosite Share
Beckman Coulter, Inc. announced that it has entered into a revised merger agreement with Biosite, Inc. Under the terms of the revised merger agreement, Beckman Coulter will acquire all of Biosite's outstanding common stock in a cash tender offer for ...
-
Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations
(12 Apr 2007)
Biosite Incorporated announced that its Board of Directors, after consultation with its financial and legal advisors, has determined that the acquisition proposal set forth in the letter received from Inverness Medical Innovations, Inc. on April 4, ...
-
Cornell researcher works to develop cheap, quick health test for people with HIV/AIDS in developing countries
(28 Mar 2007)
A Cornell researcher is working to develop a quick, simple and cheap immune-system test for people in the developing world. It could help HIV/AIDS sufferers in the poorest countries get appropriate treatment to extend their lives, possibly by as ...
-
Beckman Coulter to Acquire Biosite Incorporated
(27 Mar 2007)
Beckman Coulter, Inc. and Biosite(R) Incorporated announced that they have entered into a definitive merger agreement under which Beckman Coulter will acquire all of Biosite's outstanding common stock in a cash tender offer of $85.00 per share, or ...
-
Beckman Coulter Licenses Roche`s Real Time PCR Patent Portfolio
(24 Jul 2006)
Beckman Coulter, Inc. has acquired an In Vitro Diagnostics product license to all real-time polymerase chain reaction (PCR) patents and pending patent applications owned or controlled by Roche Diagnostics, a division of F. Hoffmann-La Roche Ltd, ...
-
Applera and Beckman Coulter Announce Terms of Settlement of Legal Disputes regarding PCR technology
(28 Apr 2006)
Applera Corporation and Beckman Coulter, Inc. jointly announced that they have established the terms of a settlement to resolve all outstanding legal disputes between the parties regarding claims to certain Beckman Coulter patented capillary ...
-
Beckman Coulter Signs Rapid Diagnostics Supply Agreement with Princeton BioMeditech Corporation
(25 Aug 2005)
In a move that underscores its growing commitment to the market for rapid diagnostic medical test products, Beckman Coulter, Inc. announced that it has entered into a supply relationship with Princeton BioMeditech Corporation (PBM). Under the ...
-
Beckman Coulter Names Scott Garrett CEO
(26 Jan 2005)
Beckman Coulter, Inc. announced that Scott Garrett has been named chief executive officer (CEO) of the corporation, effective February 21, 2005. Garrett, currently president and chief operating officer (COO), succeeds retiring CEO, John P. Wareham. ...
-
Beckman Coulter Signs Distribution Agreement with pION INC for Automated Drug Permeability Analysis
(15 Dec 2004)
Beckman Coulter, Inc. announced it has entered into a 5-year distribution agreement with pION INC of Woburn, Mass., to deliver a fully validated solution for the automation of in vitro drug permeability measurements. . "This agreement expands ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon